Researchers use functional test to measure the effect of inherited variants in BRCA2 cancer gene

By | February 21, 2021
Researchers at Mayo Clinic have combined results from a functional test measuring the effect of inherited variants in the BRCA2 breast and ovarian cancer gene with clinical information from women who received genetic testing to determine the clinical importance of many BRCA2 variants of uncertain significance (VUS).